Heska Corporation Operating Cash Flow 2011-2026 | HSKA

Annual Operating Cash Flow Heska Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-21.8 M	6.25 M	-656 K	3.3 M	13.3 M	10.4 M	5.86 M	2.12 M	5.55 M	-1.41 M	-369 K	4.89 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.3 M	-21.8 M	2.28 M

Quarterly Operating Cash Flow Heska Corporation

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-9.16 M	-	-18.7 M	-16.6 M	-17.7 M	-	5.27 M	7.15 M	1.34 M	-	-8.1 M	-13.1 M	-4.76 M	-	-3.28 M	-5.36 M	727 K	-	6.46 M	4.5 M	4.21 M	-	6.28 M	4.86 M	1.93 M	-	1.88 M	278 K	-637 K	-	-932 K	-282 K	-1.39 M	-	3.6 M	3.16 M	5.22 M	-	-1.26 M	-1.06 M	510 K	-	1.02 M	2.07 M	-255 K	-	5.62 M	3.57 M	-151 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.15 M	-18.7 M	-892 K

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.48 B	$ 121.25	2.54 %	$ 36.9 B	USA
Burning Rock Biotech Limited BNR	-478 M	$ 21.33	-5.2 %	$ 230 M	China
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
CareDx, Inc CDNA	42 M	$ 22.09	-1.47 %	$ 1.18 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-29.1 M	$ 1.52	4.12 %	$ 2.02 M	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Castle Biosciences CSTL	64.9 M	$ 25.08	2.13 %	$ 697 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	738 M	$ 183.47	3.69 %	$ 9.09 B	USA
Danaher Corporation DHR	6.42 B	$ 195.86	1.07 %	$ 140 B	USA
Interpace Biosciences IDXG	5.83 M	$ 2.0	-9.09 %	$ 8.85 M	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Medpace Holdings MEDP	713 M	$ 519.83	0.81 %	$ 15 B	USA
Illumina ILMN	837 M	$ 134.35	1.23 %	$ 21.4 B	USA
Myriad Genetics MYGN	1.8 M	$ 5.19	3.7 %	$ 481 M	USA
NeoGenomics NEO	5.23 M	$ 8.38	2.63 %	$ 1.07 B	USA
Neogen Corporation NEOG	58.2 M	$ 9.64	4.33 %	$ 2.09 B	USA
Fulgent Genetics FLGT	21.1 M	$ 16.34	1.3 %	$ 494 M	USA
Precipio PRPO	685 K	$ 28.81	-0.66 %	$ 46.2 M	USA
Guardant Health GH	-185 M	$ 90.83	5.99 %	$ 11.4 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-7.17 M	$ 2.83	-	$ 91.8 K	USA
Biomerica BMRA	-3.84 M	$ 2.18	-0.91 %	$ 5.01 M	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	1.29 B	$ 119.42	3.32 %	$ 9.85 B	Irlanda
Laboratory Corporation of America Holdings LH	1.64 B	$ 273.05	2.51 %	$ 22.7 B	USA
Senseonics Holdings SENS	-59.1 M	$ 6.8	0.44 %	$ 284 M	USA
Celcuity CELC	-153 M	$ 123.43	-1.45 %	$ 5.77 B	USA
Soleno Therapeutics SLNO	46.8 M	$ 52.67	0.18 %	$ 2.68 B	USA
Lantheus Holdings LNTH	390 M	$ 84.14	0.26 %	$ 5.68 B	USA
Neuronetics STIM	-20.4 M	$ 1.44	2.86 %	$ 95 M	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 195.61	2.17 %	$ 21.7 B	USA
ENDRA Life Sciences NDRA	-5.18 M	$ 6.01	16.27 %	$ 4.73 M	USA
Thermo Fisher Scientific TMO	7.82 B	$ 526.97	2.13 %	$ 199 B	USA
Trinity Biotech plc TRIB	13.2 M	$ 0.68	-2.63 %	$ 61.9 M	Irlanda